MAI Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.1K | Sell |
2,793
-146
| -5% | -$4.03K | ﹤0.01% | 1542 |
|
|
2025
Q1 | $83.3K | Sell |
2,939
-8
| -0.3% | -$227 | ﹤0.01% | 1410 |
|
|
2024
Q4 | $123K | Buy |
+2,947
| New | +$123K | ﹤0.01% | 1278 |
|
|
2024
Q3 | – | Sell |
-4,622
| Closed | -$549K | – | 1152 |
|
|
2024
Q2 | $549K | Buy |
4,622
+380
| +9% | +$45.1K | 0.01% | 756 |
|
|
2024
Q1 | $452K | Sell |
4,242
-513
| -11% | -$54.7K | ﹤0.01% | 814 |
|
|
2023
Q4 | $473K | Buy |
4,755
+1,244
| +35% | +$124K | 0.01% | 704 |
|
|
2023
Q3 | $363K | Sell |
3,511
-1,034
| -23% | -$107K | 0.01% | 727 |
|
|
2023
Q2 | $552K | Sell |
4,545
-453
| -9% | -$55K | 0.01% | 588 |
|
|
2023
Q1 | $768K | Sell |
4,998
-821
| -14% | -$126K | 0.01% | 481 |
|
|
2022
Q4 | $1.05M | Buy |
5,819
+2,051
| +54% | +$368K | 0.02% | 397 |
|
|
2022
Q3 | $446K | Sell |
3,768
-151
| -4% | -$17.9K | 0.01% | 574 |
|
|
2022
Q2 | $560K | Buy |
3,919
+1,068
| +37% | +$153K | 0.01% | 498 |
|
|
2022
Q1 | $491K | Buy |
2,851
+535
| +23% | +$92.1K | 0.01% | 541 |
|
|
2021
Q4 | $588K | Sell |
2,316
-233
| -9% | -$59.2K | 0.01% | 507 |
|
|
2021
Q3 | $981K | Buy |
2,549
+76
| +3% | +$29.2K | 0.02% | 362 |
|
|
2021
Q2 | $581K | Buy |
2,473
+351
| +17% | +$82.5K | 0.01% | 461 |
|
|
2021
Q1 | $278K | Buy |
+2,122
| New | +$278K | 0.01% | 576 |
|
|
2020
Q4 | – | Sell |
-17,431
| Closed | -$1.23M | – | 641 |
|
|
2020
Q3 | $1.23M | Buy |
17,431
+3,431
| +25% | +$243K | 0.04% | 228 |
|
|
2020
Q2 | $899K | Buy |
+14,000
| New | +$899K | 0.03% | 281 |
|